Zeo ScientifiX (ZEOX) Non-Current Debt (2016 - 2024)
Zeo ScientifiX (ZEOX) posted quarterly Non-Current Debt of $725000.0 for Q4 2024, up 228.05% year-over-year from $221000.0 in Q4 2023, and up 228.21% quarter-over-quarter from $220897.0 in Q2 2024.
Zeo ScientifiX (ZEOX) Non-Current Debt (2016 - 2024) Analysis & Trends
Zeo ScientifiX's Non-Current Debt history runs 7 years deep, the most recent figure standing at $725000.0 for Q4 2024.
- In Q4 2024, Non-Current Debt rose 228.05% year-over-year to $725000.0; the TTM figure through Oct 2024 stood at $725000.0 (up 228.05% YoY), while the FY2024 annual figure was $725000.0, up 228.05% from the prior year.
- Non-Current Debt for Q4 2024 stood at $725000.0, up from $220897.0 in the prior quarter.
- The five-year high for Non-Current Debt was $725000.0 in Q4 2024, with the low at $119146.0 in Q4 2020.
- The 5-year median for Non-Current Debt is $220897.0 (2022), against an average of $279764.6.
- The sharpest annual moves came in 2022 and 2024: Non-Current Debt sank 33.41% in 2022, then surged 228.05% in 2024.
- Zeo ScientifiX's Non-Current Debt stood at $119146.0 in 2020, then surged by 178.44% to $331748.0 in 2021, then tumbled by 33.41% to $220897.0 in 2022, then advanced by 0.05% to $221000.0 in 2023, then soared by 228.05% to $725000.0 in 2024.
- Business Quant data shows ZEOX's Non-Current Debt at $725000.0 in Q4 2024, $220897.0 in Q2 2024, and $220897.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 882.16 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 546.77 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 8.96 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 360.97 Mn |
| 10 | Zeo ScientifiX | 11.02 Mn | 9.17 Mn | 2.06 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2024 | 725,000.00 |
| Apr 30, 2024 | 220,897.00 |
| Jan 31, 2024 | 220,897.00 |
| Oct 31, 2023 | 221,000.00 |
| Apr 30, 2023 | 220,897.00 |
| Jan 31, 2023 | 207,808.00 |
| Oct 31, 2022 | 220,897.00 |
| Jan 31, 2022 | 309,356.00 |
| Oct 31, 2021 | 331,748.00 |
| Oct 31, 2020 | 119,146.00 |
| Oct 31, 2019 | 153,180.00 |
| Jul 31, 2019 | 165,779.00 |
| Apr 30, 2019 | 177,396.00 |
| Jul 31, 2016 | 100,000.00 |
| Apr 30, 2016 | 100,000.00 |
| Jan 31, 2016 | 65,000.00 |